Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-11-22 06:16 am Purchase | 13G | OVID THERAPEUTICS INC OVID | TAKEDA PHARMACEUTICAL CO LTD TAK | 5,531,996 11.6% | 3,750,000 (+210.44%) | View |
| 2019-11-06 06:08 am Purchase | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 8,672,000 24.7% | 8,672,000 (New Position) | View |
| 2019-11-05 5:40 pm Purchase | 13G | BIOMX INC PHGE | TAKEDA PHARMACEUTICAL CO LTD TAK | 2,470,935 10.82% | 2,470,935 (New Position) | View |
| 2019-09-10 06:21 am Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | TAKEDA PHARMACEUTICAL CO LTD TAK | 1,859,151 8.1% | 1,859,151 (New Position) | View |
| 2019-05-20 1:18 pm Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | TAKEDA PHARMACEUTICAL CO LTD TAK | 2,679,802 9.9% | 2,679,802 (New Position) | View |